300562.SZ
乐心医疗
SZSE · Healthcare · C 制造业 · CN
CNY 14.94
−0.60%Year over year
Reported trailing growth
- Revenue
- -1.2%
- EBITDA
- —
- EBIT
- +38.7%
- EPS
- +26.9%
- Free cash flow
- +13.0%
- Operating cash flow
- -2.9%
Forward estimates
Based on analyst estimates
- Revenue
- +56.5%
- EBITDA
- +428.4%
- EPS
- +366.0%
Three-year CAGR
- Revenue
- -2.5%
- EBITDA
- +34.0%
- EBIT
- +58.1%
- Net income
- +54.5%
- EPS
- +53.6%
- Free cash flow
- +29.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026